VeroPharm will not pay out dividends for 2012
MOSCOW. June 28 (Interfax) - The shareholders in OJSC VeroPharm decided at their annual general meeting to waive dividends for 2012 and use earnings for economic growth and development, the company reported.
VeroPharm did not pay out dividends for 2011, either. It paid 19 rubles per share, or a total of 190 million rubles, in 2010 dividends and did not pay dividends for 2009, 2008 or 2007.
The shareholders also elected a new board of directors, which includes: General Director of Pharmacy Chain 36.6 Artem Bektemirov, Chairman of the Board of Directors of 36.6 Sergei Krivosheyev, VeroPharm CEO Marina Penkova, VeroPharm's Advisor for Legal Affairs Victor Vasiliev, Executive Director of the Investor Protection Association Denis Kulikov, Chairman of the Audit Committee at 36.6 Vasily Rudomino, and member of the Strategic Development Committee at 36.6 Arkady Gibov. The newcomers are: analyst at ratings agency Expert RA Andrei Vinkov and General Director of LLC Dialog Artem Stepanchikov. CJSC Deloitte & Touche CIS was confirmed as the company's auditor.
